Galectin Therapeutics stock price
갈렉틴 테라퓨틱스NASDAQ:GALT · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Galectin Therapeutics last closed at $3.90 (+3.72%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -9.2×. Its overall grade ranks 141 of 739 stocks in Healthcare.
About this company
Galectin Therapeutics last closed at $3.90 (+3.72%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 141/739
Valuation grade A+
Related stocks
- Eli LillyCustomer
갈렉틴 계열 질환 치료제 개발에서 임상·상업 파트너십 가능성이 언급되는 대형 제약사
- NovartisCompetitor
간질환·섬유화 등 질환 영역에서 유사한 신약 개발 경쟁을 벌이는 글로벌 제약사
- Gilead SciencesCompetitor
NASH/MASH 및 간질환 치료제 개발 경쟁에서 자주 비교되는 대형 바이오/제약사
About Galectin Therapeutics
- What technical signals does Galectin Therapeutics (GALT) have?
- Galectin Therapeutics current technical signals: no active technical signal.
- Is Galectin Therapeutics a cup-and-handle pattern?
- No. Galectin Therapeutics has no valid Cup signal right now.
- What published figures are available for Galectin Therapeutics?
- Market cap: $251.44M. Trailing 12 months PER: -9.2×. Latest quarter PBR: -1.88×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Galectin Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).